Dominican Republic vs Eswatini: Drug use disorder deaths by sex
Dominican Republic
3.12 deaths
in 2021
Eswatini
4.14 deaths
in 2021
Dominican Republic rank
113th
Eswatini rank
110th
Drug use disorder deaths by sex over time
- Dominican Republic
- Eswatini
How they compare
Eswatini currently reports 4.14 deaths against 3.12 deaths in Dominican Republic, a difference of 1.02 deaths.
That makes Eswatini's figure about 1.3 times Dominican Republic's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Dominican Republic ahead.
Dominican Republic ranks 113th and Eswatini ranks 110th of 194 countries.
Across the 3 decades both report, Dominican Republic averaged higher in 1 and Eswatini in 2.
Head to head by decade
| Decade | Dominican Republic | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.61 deaths | 2.44 deaths | 0.172 deaths | Dominican Republic |
| 2010s | 3.6 deaths | 3.84 deaths | 0.233 deaths | Eswatini |
| 2020s | 3.09 deaths | 3.6 deaths | 0.515 deaths | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths by sex, Dominican Republic or Eswatini?
- Eswatini, at 4.14 deaths against 3.12 deaths in Dominican Republic as of 2021.
- What is the difference in drug use disorder deaths by sex between Dominican Republic and Eswatini?
- 1.02 deaths, with Eswatini ahead.
- How many years of comparable data are there for Dominican Republic and Eswatini?
- 22 years are reported by both, from 2000 to 2021.
- How do Dominican Republic and Eswatini rank globally for drug use disorder deaths by sex?
- Dominican Republic ranks 113th and Eswatini ranks 110th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in females.